The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
The Prevalence of Diabetic Retinopathy Among Adults in the United States
Abstract
OBJECTIVE: To determine the prevalence of diabetic retinopathy among adults 40 years and older in the United States. METHODS: Pooled analysis of data from 8 population-based eye surveys was used to estimate the prevalence, among persons with diabetes mellitus (DM), of retinopathy and of vision-threatening retinopathy-defined as proliferative or severe nonproliferative retinopathy and/or macular edema. Within strata of age, race/ethnicity, and gender, US prevalence rates were estimated by multiplying these values by the prevalence of DM reported in the 1999 National Health Interview Survey and the 2000 US Census population. RESULTS: Among an estimated 10.2 million US adults 40 years and older known to have DM, the estimated crude prevalence rates for retinopathy and vision-threatening retinopathy were 40.3% and 8.2%, respectively. The estimated US general population prevalence rates for retinopathy and vision-threatening retinopathy were 3.4% (4.1 million persons) and 0.75% (899 000 persons). Future projections suggest that diabetic retinopathy will increase as a public health problem, both with aging of the US population and increasing age-specific prevalence of DM over time. CONCLUSION: Approximately 4.1 million US adults 40 years and older have diabetic retinopathy; 1 of every 12 persons with DM in this age group has advanced, vision-threatening retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.477 · Cited by 2,616
Stratton, I. M., Kohner, E. M., Aldington, S. J., Turner, R. C., Holman, R. R., Manley, S. E., & Matthews, D. R. (2001) · Diabetologia · doi:10.1007/s001250051594 · Cited by 1,019
Projection of Diabetes Burden Through 2050
Boyle, J. P., Honeycutt, A. A., Narayan, K. M. V., Hoerger, T. J., Geiss, L. S., Chen, H., & Thompson, T. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.1936 · Cited by 1,004
Diabetes and Diabetic Retinopathy in a Mexican-American Population
West, S. K., Klein, R., Rodriguez, J., Muñoz, B., Broman, A. T., Sanchez, R., & Snyder, R. (2001) · Diabetes Care · doi:10.2337/diacare.24.7.1204 · Cited by 160
Self-citation
Cited by
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
Self-citationCheung, N., Mitchell, P., & Wong, T. Y. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62124-3 · Cited by 3,288
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045
Teo, Z. L., Tham, Y.-C., Yu, M., Chee, M. L., Rim, T. H., Cheung, N., Bikbov, M. M., Wang, Y. X., Tang, Y., Lu, Y., et al. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2021.04.027 · Cited by 2,420
Antonetti, D. A., Klein, R., & Gardner, T. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1005073 · Cited by 1,659
Self-citationEffects of medical therapies on retinopathy progression in type 2 diabetes
The ACCORD Study Group and ACCORD Eye Study Group (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001288 · Cited by 1,311
Prevalence of Diabetic Retinopathy in the United States, 2005-2008
Zhang, X., Saaddine, J. B., Chou, C.-F., Cotch, M. F., Cheng, Y. J., Geiss, L. S., Gregg, E. W., Albright, A. L., Klein, B. E. K., & Klein, R. (2010) · JAMA · doi:10.1001/jama.2010.1111 · Cited by 1,196
Self-citationRole of Inflammation in Diabetic Retinopathy
Rübsam, A., Parikh, S., & Fort, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040942 · Cited by 750
Prevalence of and Risk Factors for Diabetic Macular Edema in the United States
Varma, R., Bressler, N. M., Doan, Q. V., Gleeson, M., Danese, M., Bower, J. K., Selvin, E., Dolan, C., Fine, J., Colman, S., et al. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.2854 · Cited by 423
Golden, S. H., Brown, A., Cauley, J. A., Chin, M. H., Gary-Webb, T. L., Kim, C., Sosa, J. A., Sumner, A. E., & Anton, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2043 · Cited by 405
Saaddine, J. B. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.12.1740 · Cited by 377
Prevalence of Diabetic Retinopathy in the US in 2021
Lundeen, E. A., Burke-Conte, Z., Rein, D. B., Wittenborn, J. S., Saaddine, J., Lee, A. Y., & Flaxman, A. D. (2023) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2023.2289 · Cited by 293
Neutrophil extracellular traps target senescent vasculature for tissue remodeling in retinopathy
Binet, F., Cagnone, G., Crespo-Garcia, S., Hata, M., Neault, M., Dejda, A., Wilson, A. M., Buscarlet, M., Mawambo, G. T., Howard, J. P., et al. (2020) · Science · doi:10.1126/science.aay5356 · Cited by 283
Zhang, X., Cotch, M. F., Ryskulova, A., Primo, S. A., Nair, P., Chou, C.-F., Geiss, L. S., Barker, L. E., Elliott, A. F., Crews, J. E., et al. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.08.045 · Cited by 277
Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy
Oubaha, M., Miloudi, K., Dejda, A., Guber, V., Mawambo, G., Germain, M.-A., Bourdel, G., Popovic, N., Rezende, F. A., Kaufman, R. J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9440 · Cited by 259
Gong, Q., Gregg, E. W., Wang, J., An, Y., Zhang, P., Yang, W., Li, H., Li, H., Jiang, Y., Shuai, Y., et al. (2011) · Diabetologia · doi:10.1007/s00125-010-1948-9 · Cited by 251
Regulation of blood-retinal barrier cell-junctions in diabetic retinopathy
Rudraraju, M., Narayanan, S. P., & Somanath, P. R. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105115 · Cited by 217
Li, J. Q., Welchowski, T., Schmid, M., Letow, J., Wolpers, C., Pascual-Camps, I., Holz, F. G., & Finger, R. P. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-019-00560-z · Cited by 179
Crespo-Garcia, S., Tsuruda, P. R., Dejda, A., Ryan, R. D., Fournier, F., Chaney, S. Y., Pilon, F., Dogan, T., Cagnone, G., Patel, P., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.01.011 · Cited by 182
Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy
Huang, Y., Wang, Z., Ma, H., Ji, S., Chen, Z., Cui, Z., Chen, J., & Tang, S. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.646348 · Cited by 180
How safe is the use of thiazolidinediones in clinical practice?
Rizos, C., Elisaf, M., Mikhailidis, D., & Liberopoulos, E. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330802597821 · Cited by 161
Ahmed, J., Ward, T. P., Bursell, S.-E., Aiello, L. M., Cavallerano, J. D., & Vigersky, R. A. (2006) · Diabetes Care · doi:10.2337/dc06-0295 · Cited by 152
Patient-Driven Diabetes Care of the Future in the Technology Era
Ashrafzadeh, S., & Hamdy, O. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.005 · Cited by 111
Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden
Heintz, E., Wiréhn, A.-B., Peebo, B. B., Rosenqvist, U., & Levin, L.-Å. (2010) · Diabetologia · doi:10.1007/s00125-010-1836-3 · Cited by 107
Racial Disparity of Eye Examinations Among the U.S. Working-Age Population With Diabetes: 2002–2009
Shi, Q., Zhao, Y., Fonseca, V., Krousel-Wood, M., & Shi, L. (2014) · Diabetes Care · doi:10.2337/dc13-1038 · Cited by 94
Population-Based Studies in Ophthalmology
Wong, T. Y., & Hyman, L. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.07.048 · Cited by 74
The Prevalence of Diabetic Retinopathy in Australian Adults with Self-Reported Diabetes
Keel, S., Xie, J., Foreman, J., van Wijngaarden, P., Taylor, H. R., & Dirani, M. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.02.004 · Cited by 73
Bursell, S.-E., Fonda, S. J., Lewis, D. G., & Horton, M. B. (2018) · PLOS ONE · doi:10.1371/journal.pone.0198551 · Cited by 68
Teo, Z. L., Tham, Y.-C., Yu, M., Cheng, C.-Y., Wong, T. Y., & Sabanayagam, C. (2020) · Eye · doi:10.1038/s41433-020-0776-5 · Cited by 62
An, J., Niu, F., Turpcu, A., Rajput, Y., & Cheetham, T. C. (2018) · Ophthalmic Epidemiology · doi:10.1080/09286586.2018.1424344 · Cited by 55
Racial disparities in the screening and treatment of diabetic retinopathy
Coney, J. M., & Scott, A. W. (2022) · Journal of the National Medical Association · doi:10.1016/j.jnma.2021.12.011 · Cited by 53
Thapa, R., Joshi, D. M., Rizyal, A., Maharjan, N., & Joshi, R. D. (2014) · Nepalese Journal of Ophthalmology · doi:10.3126/nepjoph.v6i1.10760 · Cited by 48
Patel, D., Ananthakrishnan, A., Lin, T., Channa, R., Liu, T. Y. A., & Wolf, R. M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11237120 · Cited by 43
Dow, E. R., Khan, N. C., Chen, K. M., Mishra, K., Perera, C., Narala, R., Basina, M., Dang, J., Kim, M., Levine, M., et al. (2023) · Ophthalmology Science · doi:10.1016/j.xops.2023.100330 · Cited by 40
Henriques, J., Vaz-Pereira, S., Nascimento, J., & Rosa, P. C. (2015) · Acta Médica Portuguesa · doi:10.20344/amp.5361 · Cited by 33
Diaz, E. A., Seifert, M. L., Gruning, V., Stadnick, N. A., Lugo-Butler, E., Servin, A. N., Rodríguez-Rosales, C. I., Geremia, C., Ramachandra, C., Bhaskaranand, M., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.38114 · Cited by 9
Metadata
- Venue
- Archives of Ophthalmology
- Publisher
- American Medical Association (AMA)
- Published
- 2004-04-01
- Volume
- 122
- Issue
- 4
- Pages
- 552
- ISSN
- 0003-9950 (ISSN-L)
- OpenAlex
- W2124521298
- Cited by
- 1,148
- References
- 4
- FWCI
- 32.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
